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Abstract
Aims/hypothesis
To describe barriers to physical activity (PA) in type 2 diabetes patients and their general
practitioners (GPs), looking for practitioner’s influence on PA practice of their patients.
Methods
We conducted a cross-sectional study on GPs (n = 48) and their type 2 diabetes patients
(n = 369) measuring respectively barriers to prescribe and practice PA using a self-assess-
ment questionnaire: barriers to physical activity in diabetes (BAPAD). Statistical analysis
was performed accounting hierarchical data structure. Similar practitioner’s patients were
considered a cluster sharing common patterns.
Results
The higher the patient’s BAPAD score, the higher the barriers to PA, the higher the risk to
declare practicing no PA (p<0.001), low frequency and low duration of PA (p<0.001). A high
patient’s BAPAD score was also associated with a higher risk to have HbA1c7% (53
mmol/mol) (p = 0.001). The intra-class correlation coefficient between type 2 diabetes
patients and GPs was 34%, indicating a high cluster effect. A high GP’s BAPAD score,
regarding the PA prescription, is predictive of a high BAPAD score with their patients,
regarding their practice (p = 0.03).
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Conclusion/interpretation
Type 2 diabetes patients with lower BAPAD score, thus lower barriers to physical activity,
have a higher PA level and a better glycemic control. An important and deleterious cluster
effect between GPs and their patients is demonstrated: the higher the GP’s BAPAD score,
the higher the type 2 diabetes patients’ BAPAD score. This important cluster effect might
designate GPs as a relevant lever for future interventions regarding patient’s education
towards PA and type 2 diabetes management.
Introduction
Physical activity (PA) is a cornerstone in type 2 diabetes management, significantly improving
glycemic control, lowering HbA1c by an average of 0.6–0.8% [1,2]. This is clinically relevant
since HbA1c reduction is associated with improved morbidity and mortality outcomes [3].
The American Diabetes Association emphasizes the benefits of regular PA in the treatment
of type 2 diabetes and advises to engage in moderate-intensity PA for at least 30 min on most
days of the week [4]. However, despite the promotion of an active lifestyle from multilevel
agencies, it is apparent that too few type 2 diabetes patients follow these recommendations.
Actually, adults with diabetes are less likely to engage in regular PA than the general adult pop-
ulation [5] and only 23% of older adults with type 2 diabetes report more than 60 min of
weekly PA in the US [6]. Therefore, factors that impede PA in type 2 diabetes need to be identi-
fied in order to guide future interventions.
To meet the challenges facing type 2 diabetes, interventions need to acknowledge con-
straints on behavioral changes and to identify effective strategies to reverse behavioral trends
towards physical inactivity [7]. Representations and beliefs with type 2 diabetes patients and
their general practitioners (GP) regarding PA practice might likely be wrong, so deleterious.
Assuming that GPs’ promotion and prescription of PA influence actual practice in type 2 dia-
betes patients, GPs’ beliefs towards PA in these patients might be a key issue.
In 2006, Dube et al. [8] developed a questionnaire (Barriers to Physical activity in Diabetes:
BAPAD) that measured perceived barriers to practice regular PA for diabetes patients in order
to identify potential targets for future interventions.
We aimed to investigate the possible link between PA in type 2 diabetes patients and GP’s
attitude regarding PA promotion. To carry out such an investigation testing for this possible
influence of GP’s on their patients, we performed a survey over a whole French region and
simultaneously measured barriers to PA practice in type 2 diabetes patients using the original
version of BAPAD questionnaire and the GPs’ reluctance in prescribing PA for such patients
using an adapted version of BAPAD questionnaire.
Methods
Study design
We conducted a cross-sectional study on GPs and their type 2 diabetes patients in the
Auvergne region of France. All the private GPs (n = 970) practicing in this region were invited
to participate in our survey. They were mailed a packet that included a letter describing the
study, an acceptance/refusal form, and a postage-paid return envelope. A phone-call reminder
was made for non-respondents 3 weeks after the packet was mailed. GP’s written consent was
actually the first condition to participate in the survey and start patient’s proposal to enter the
survey. A medical representative met each physician who agreed to participate 5–6 weeks after
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the initial mailing, and delivered a form for the physician (GP’s form) and a set of additional
forms intended for their type 2 diabetes patients (patients forms). Each GP was asked to enroll
up to 10 patients with type 2 diabetes. The only exclusion criterion was treatment with insulin
(S1 Fig). The instructions were first to complete the GP’s form and then to start including
patients, allowing them to complete the form on their own. Each physician was assigned a
number to return with the questionnaire. The number assigned to each physician was attached
to a number assigned to each of his/her patient. This was only done to relate each patient to his
physician while keeping the data file anonymous. About 4 weeks later, the same medical repre-
sentative collected the forms during a meeting with the GP. The study was conducted, by the
University Hospital of Clermont-Ferrand and was approved by the appropriate IRBs (CCPPRB
d’Auvergne for any clinical study and CPP Sud-Est VI specifically for observational study) in
accordance with the protocol of Helsinki. Our local IRB approved the whole content of the pro-
tocol of our survey, including all participants’ recruitment (GPs and patients). All the informa-
tion used and analyzed in our survey was obtained exclusively from self-administered forms
and our study was completely anonymous regarding both GPs and patients whose linkage was
carried-out through numbers assigned to patients which included the number of their corre-
sponding GP.
Forms and questionnaires
Patient data were collected during a visit to their GPs. The first part of the patient’s self-adminis-
tered form asked for demographic data history, and if they knew the last value of their HbA1c,
and if so, its value. This first part of the questionnaire also asked the patient both the frequency,
i.e. number of at least 30 min long sessions per week (categorized as “1–2 times/week”, “3–4” or
“everyday”) and the duration of PA per week (categorized as “under 2h”, “2-3h” or “over 3h”).
“Regular PA” was defined as “2h or more per week at least 3 times per week”. The strata “1 to 2
times per week” (for frequency) and “under 2h” (for duration) were considered the reference cat-
egories to display the results. A second section of the questionnaire dealt with their GP’s attitude
regarding behavioral modifications. Type 2 diabetes patients were asked to rate the relative
importance of the three following therapeutic measures to manage their disease: glucose-lowering
medication, regular PA and quitting smoking. A third section of the questionnaire assessed the
type 2 diabetes patient’s barriers to PA using the original version of the BAPAD questionnaire.
The GP’s form was based on a similar self-administered form, and also included three parts.
The first part sought information concerning demographic data, professional data and per-
sonal PA. The second part inquired about GPs’medical care for type 2 diabetes, with particular
emphasis on promotion or education on PA for the management of type 2 diabetes. The third
part assessed the GPs’ barriers to promote or prescribe PA to their type 2 diabetes patients
through a slightly adapted version of the BAPAD questionnaire.
The original BAPAD questionnaire measures the perceived barriers towards undertaking
regular PA by type 2 diabetics using 11 items [8]. Patients are asked to rate, using a seven-level
rating scale, the likelihood that each of the 11 items would keep them from practicing regular
PA during the next 6 months (Table 1). We slightly adapted the phrasing to evaluate the GPs’
barriers regarding the prescription of PA while using the same seven-level rating scale to indi-
cate the likelihood that each of the same 11 items would keep them from prescribing regular
PA during the next 6 months to their type 2 diabetes patients.
Statistical analyses
Continuous variables were displayed as mean±standard error (mean±SE). Categorical and
ordinal variables were described using frequencies and percentages. For each item of the
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BAPAD questionnaire, we displayed both the distribution and summary statistics (mean±SE).
The BAPAD score was defined as the mean of the 11 BAPAD items.
Because we used the BAPAD scale for type 2 diabetes patients and their GPs, we assessed
the internal consistency of the BAPAD scale using the alpha Cronbach’s coefficient. This coef-
ficient was of 0.85 in Dube et al. who used the BAPAD scale for type 1 diabetes patients [8].
By comparing the Cronbach’s coefficients, we aimed to check that the reliability of the
BAPAD scale for type 2 diabetes patients and their GPs was at least as satisfactory as for type 1
diabetes patients.
Regarding GPs’ characteristics and their BAPAD score, relationships between categorical
variables were assessed using Fisher’s exact test, relationships between continuous variables
were assessed using Spearman’s correlation coefficient test, and relationships between categori-
cal and continuous variables were assessed using, as appropriate, either a Wilcoxon test or a
one-way Kruskal-Wallis ANOVA.To further analyze GPs’ influence regarding PA of type 2
diabetes patients, we used random-effect models accounting for hierarchical data structure
(since patients with the same GP are considered a cluster). Intra-cluster correlation coefficient
(ICC) [9] was computed.
Subsequent analyses all accounted for cluster effect and consisted in modeling patients’
BAPAD score as a continuous response variable. A first model included only the patient’s char-
acteristics (as explanatory variables), such as the disease history or the HbA1c level, and then a
larger one extended explanatory variables to GPs’ characteristics, including GPs’ BAPAD
score. Explanatory variables selections were performed through automated stepwise proce-
dures. Less than 5% of the data were incomplete and a sensitivity analysis was performed to
Table 1. The 11 items of the BAPADwith percentages andmean scores (±SE) per item for both GPs and their type 2 diabetes patients (GPs/
Patients).
BAPAD Items, GPs (A)/type 2 diabetes
patients (B). Percentages for each
rating level and GPs’/type 2 diabetes
patients’ BAPAD score Mean ±SE
Seven-level rating scale
1 2 3 4 5 6 7 Mean ±SE
1-Loss of control for diabetes 71/44 15/17 4/9 6/16 2/6 0/5 2/4 1.63±0.2/2.51±0.1
2-The risk of hypoglycemia 35/30 31/15 13/13 8/15 4/12 4/7 4/7 2.44±0.2/3.14±0.1
3-The fear of being tired 60/25 25/12 2/11 8/13 2/15 0/17 2/7 1.75±0.2/3.59±0.1
4-The fear of hurting 60/41 19/17 10/9 6/12 4/8 0/8 0/5 1.75±0.2/2.76±0.1
themselves
5-The fear of suffering a heart 25/37 19/12 19/9 21/16 6/10 8/11 2/6 2.98±0.2/3.06±0.1
attack
6-A low ﬁtness level 23/21 23/10 19/12 10/16 13/13 10/17 2/11 3.06±0.3/3.85±0.1
7-The fact that they have 77/46 17/14 4/10 0/15 0/7 2/5 0/3 1.35±0.1/2.49±0.1
diabetes
8-The risk of hyperglycaemia 85/55 13/17 0/8 0/11 0/3 2/2 0/2 1.23±0.1/2.07±0.1
9- Physical health status 6/29 6/16 13/5 29/14 21/11 15/9 10/16 4.38±0.2/3.53±0.1
10-Weather conditions 27/23 17/10 25/11 17/12 6/16 4/17 4/11 2.88±0.2/3.83±0.1
11-Their work schedule 33/57 15/6 17/7 15/9 10/5 6/5 4/11 2.90±0.3/2.56±0.1
Total 46/37 18/13 11/10 11/14 6/10 5/9 3/8 2.39±0.1/3.04±0.1
A: For GPs: “Indicate the likelihood that each of the 11 items would keep you from prescribing regular physical activity during the next 6 months to your
type 2 diabetes patients.” B: For type 2 diabetes patients: “Indicate the likelihood that each of the 11 items would keep you from practicing regular physical
activity during the next 6 months.” (Ranging from 1 = very unlikely, 2 = unlikely, 3 = rather unlikely, 4 = uncertain, 5 = rather likely, 6 = likely, 7 = very
likely).
doi:10.1371/journal.pone.0140429.t001
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confirm the robustness of our results. All statistical analyses were performed using Stata soft-
ware (StataCorp, College Station, TX, US) with a two-tailed type-I error set to 0.05.
Results
Among the 970 GPs asked to participate, 658 (68%) responded. Among these, 574 refused to
participate and 84 (13%) agreed. Among these 84 GPs, 36 (43%) did not include patients or did
not provide a complete response to the form, and so were excluded from the analysis. This left
a total of 48 GPs, and their 369 patients, who were included in our study (S1 Fig).
GPs who answered the survey were aged 48.9±1.2, and included 29 males (60.4%) and 19
females (39.6%) (Table 2). The mean number of patients included per GP was 7.7±0.9.
Regarding their personal PA, most declared occasional (n = 24, 50%) to regular PA (n = 20,
41.7%) at least three times per week, and only four (8.3%) declared no PA at all (Table 2). All
but one GP reported questioning their type 2 diabetes patients about their level of PA.
The GPs’ prescriptions showed that in first intention 43 GPs (90%) prescribed walking, 39
(81%) prescribed stopping smoking, 47 (98%) prescribed losing weight and 45 (94%) pre-
scribed PA.
Within a total rating of 10 points, GPs ranged their priority among three measures for man-
aging diabetes, resulting in a mean score of 6.3±0.3 points for lifestyle measures (exercise and
nutrition), 2.8±0.3 for a mono-therapy (one glucose-lowering medication) and 0.9±0.2 for a bi-
therapy. All the GPs declared allotting time during their consultation to prescribing PA, how-
ever, most (n = 40, 83.3%) spent less than 10 min (Table 2).
A huge majority of GPs (n = 39, 81.3%) had received at least one medical training session
on the management of type 2 diabetes in the last 3 years, which had focused on PA, nutrition
or medication. Only a minority (n = 22, 45.8%) wanted a new medical training on PA.
No significant association was found between any of the demographic or professional char-
acteristics of the GPs and their BAPAD scores. Similarly, we did not find any association
between GPs’ BAPAD score and GPs’ level of PA, prescription to stop smoking, to lose weight,
to practice PA or walking. Regarding the remaining GPs’ characteristics, a slight trend was
found for medical training, with a lower BAPAD score for GPs who had previous training on
PA (p = 0.06).
A total of 369 patients aged 64.9±0.5 entered the survey, including 218 males (59%) and 151
females (41%). Diabetes had been discovered 9.7±7.6 years prior to the study. In addition, 244
(66%) knew their last HbA1c value, which was 7.27±0.08% (56 mmol/mol). When asked
whether they had regular PA (at least 30 min on each occasion), 177 (48%) answered positively.
However, only 169 (45.8%) declared practicing PA at least three times a week and among
them, 99 (26.8%) had daily PA. Regarding duration and frequency, 146 out of 369 (36.9%) ful-
filled the definition of regular PA (Table 2).
Most patients (n = 307, 83.2%) had been asked by their GPs to practice PA since the discovery
of their type 2 diabetes (Table 2). However, unlike their GPs, type 2 diabetes patients gave the
greatest priority to medication to manage their diabetes, with a mean value of 6.3±0.1 within a
total rating of 10 points. The role of PA was given in second position, with a mean of 2.9±0.1.
The internal consistency of the BAPAD scale assessed by the alpha Cronbach’s coefficient
was of 0.87 regarding patient’s questionnaire, which indicates that the reliability of the barriers
scale is very satisfactory, at least as satisfactory as in Dube et al. who found a coefficient of 0.85
for BAPAD questionnaire in type 1 diabetes [8]. The alpha Cronbach’s coefficient for GPs
questionnaire was 0.83 which appeared also acceptable according to the literature [10].
The GPs’ and patients’ BAPAD scores are respectively described with mean±SE (Table 1).
Analyzing GPs’ and patients’ BAPAD, we found that the main barriers held in common between
General Practitioners’ Barriers to Prescribe Physical Activity in Type 2 Diabetes Patients
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Table 2. GPs’ BAPAD score regarding GPs’ characteristics (A), type 2 diabetes patients’ BAPAD score regarding patients’ characteristics (B).
A : GPs’ characteristics N (%) GP’s BAPAD p-value
Department Allier (03) 4 (8.3) 2.16±0.21 0.70
Department Cantal (15) 3 (6.3) 2.30±0.03 0.70
Department Haute-Loire (43) 8 (16.7) 2.09±0.31 0.70
Department Puy-de-Dôme (63) 33 (68.8) 2.50±0.17 0.70
GP’s gender Female 19 (39.6) 2.51±0.23 0.82
GP’s gender Male 29 (60.4) 2.32±0.15 0.82
Location Rural 15 (31.3) 2.45±0.29 0.90
Location Urban 21 (43.8) 2.41±0.19 0.90
Location Both 12 (25.0) 2.29±0.16 0.90
Physical activity None 4 (8.3) 2.23±0.41 0.84
Physical activity Occasionally 24 (50.0) 2.38±0.19 0.84
Physical activity Regularly 20 (41.7) 2.44±0.20 0.84
Time spent prescribing exercise <10 min 40 (40) 2.46±0.14 0.43
Time spent prescribing exercise >10 min 8 (8) 2.08±0.34 0.43
Medical training on DT2 No 9 (18.8) 2.34±0.13 0.97
Medical training on DT2 Yes 39 (81.3) 2.41±0.15 0.97
Medical training on activity No 23 (47.9) 2.65±0.17 0.05
Medical training on activity Yes 25 (52.1) 2.16±0.17 0.05
Medical training on nutrition No 14 (29.2) 2.38±0.13 0.78
Medical training on nutrition Yes 34 (70.8) 2.40±0.17 0.78
Medical training on medication No 13 (27.1) 2.22±0.14 0.48
Medical training on medication Yes 35 (72.9) 2.32±0.17 0.48
Wanting new medical training No 26 (54.2) 2.26±0.17 0.18
Wanting new medical training Yes 22 (45.8) 2.55±0.18 0.18
B : Type 2 diabetes patients characteristics N (%) Patient’s BAPAD p-value
score Mean±SE
Patient gender Female 151 (40.9) 3.17±0.11 0.14
Patient gender Male 218 (59.1) 2.95±0.09 0.14
Hba1c value known No 125 (33.9) 3.29±0.12 0.007
Hba1c value known Yes 244 (66.1) 2.90±0.08 0.007
Regular physical activity No 192 (52.0) 3.40±0.09 <0.0001
Regular physical activity Yes 177 (48.0) 2.64±0.09 <0.0001
Cycling No 328 (88.9) 3.09±0.07 0.02
Cycling Yes 41 (11.1) 2.59±0.17 0.02
Swimming No 355 (96.2) 3.05±0.07 0.16
Swimming Yes 14 (3.8) 2.55±0.25 0.16
Walking No 182 (49.3) 3.33±0.10 <0.0001
Walking Yes 187 (50.7) 2.75±0.09 <0.0001
Physical activity frequency (times per week) 1–2 200 (54.2) 3.38±0.09 <0.0001
Physical activity frequency (times per week) 3–4 70 (19.0) 2.78±0.14 <0.0001
Physical activity frequency (times per week) >4 99 (26.8) 2.52±0.11 <0.0001
Physical activity duration (h per week) <2 183 (49.6) 3.39±0.10 <0.0001
Physical activity duration (h per week) 2–3 76 (20.6) 2.98±0.14 <0.0001
Physical activity duration (h per week) >3 110 (29.8) 2.49±0.11 <0.0001
Asked to stop smoking No 230 (62.3) 2.91±0.08 0.013
Asked to stop smoking Yes 139 (37.7) 3.24±011 0.013
Asked to lose weight No 82 (22.2) 2.45±0.13 <0.0001
(Continued)
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patients and their practitioners were “the fear of suffering a heart attack” (2.9±0.2/3.1±0.1, “their
physical health status” (4.4±0.2/3.5±0.1), and “a low fitness level” (3.1±0.3/3.9±0.1).
The clustering effect evaluated by ICC between type 2 diabetes patients and GPs was 34%,
which is considered to be a high value [9]. Using mixed model, type 2 diabetes patient’s
BAPAD score was linked with all patient’s characteristics including gender (Table 3). A high
BAPAD score reflecting a high barrier to PA was significantly and positively correlated with
duration of diabetes (> 8 years) (p = 0.002). The patient’s BAPAD score was significantly
Table 2. (Continued)
Asked to lose weight Yes 287 (77.8) 3.20±0.08 <0.0001
Asked to practice activity No 62 (16.8) 2.79±0.18 0.04
Asked to practice activity Yes 307 (83.2) 3.08±0.07 0.04
doi:10.1371/journal.pone.0140429.t002
Table 3. Patient’s BAPAD according to patient’s characteristics (univariate mixedmodel).
Patient’s BAPAD p-value
Mean ± SE
Age <65 2.99 ± 0.07 0.02
Age 65 3.08 ± 0.06 0.02
Gender Male 2.95 ± 0.09 0.02
Gender Female 3.17 ± 0.11 0.02
Duration diabetes (year) 4 2.79 ± 0.06 .
Duration diabetes (year) 4–8 3.02 ± 0.07 0.17
Duration diabetes (year) >8 3.19 ± 0.07 0.002
HbA1c value known No 3.29 ± 0.12 0.001
HbA1c value known Yes 2.90 ± 0.08 0.001
HbA1c value <7(53 mmol/mol) 2.62 ± 0.06 0.001
HbA1c value 7(53 mmol/mol) 3.15 ± 0.07 0.001
Regular physical activity No 3.40 ± 0.09 <0.001
Regular physical activity Yes 2.64 ± 0.09 <0.001
Physical activity frequency (times /week) 1–2 3.38 ± 0.09 .
Physical activity frequency (times /week) 3–4 2.78 ± 0.14 <0.001
Physical activity frequency (times /week) >4 2.52 ± 0.11 <0.001
Physical activity duration (h /week) <2 3.39 ± 0.18 .
Physical activity duration (h /week) 2–3 2.98 ± 0.14 0.004
Physical activity duration (h /week) >3 2.49 ± 0.11 <0.001
Asked to stop smoking No 2.91 ± 0.08 0.83
Asked to stop smoking Yes 3.24 ± 0.11 0.83
Asked to lose weight No 2.45 ± 0.13 0.02
Asked to lose weight Yes 3.20 ± 0.08 0.02
Asked to practice physical activity No 2.79 ± 0.18 0.38
Asked to practice physical activity Yes 3.08 ± 0.07 0.38
Importance to take medics ES 0.12 [0.07, 0.18] <0.001
Importance to practice physical activity ES -0.14 [-0.20, -0.08] <0.001
Importance to stop smoking ES -0.03 [-0.12, 0.05] 0.47
Each regression coefﬁcient is interpreted as the effect size (ES).
doi:10.1371/journal.pone.0140429.t003
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higher with patients whose HbA1c was known (p = 0.001), and among these patients (n = 244)
with those with HbA1c 7% (53 mmol/mol) (p = 0.001).
BAPAD score was significantly higher with patients who declared having no PA (p<0.001),
having a low frequency and low duration of PA (p<0.001), and with patients asked to lose
weight (p = 0.02). Although not significant, we noticed similar trends regarding both patients
asked to practice PA and to stop smoking, (3.08 ± 0.07 (p = 0.38) and 3.24 ± 0.11 (p = 0.83),
respectively). Finally, the higher the priority given by patients to medication, the higher their
BAPAD score; the higher the priority given to PA, the lower the BAPAD score (Table 3).
Few GPs’ characteristics were significantly linked with the patients’ BAPAD. Among those,
the only demographic characteristic was gender: patient whose GP was male had higher
BAPAD score (p = 0.01). The higher the GPs’ BAPAD, the higher the patients’ BAPAD score
(p = 0.03) (Table 4). Patients’ BAPAD score was not linked with practitioner specialty, GPs’
physical activity, medical training or their individual type 2 diabetes management.
Table 4. Patient’s BAPAD according to general practitioner’s characteristics (univariate mixedmodel).
Patients’ BAPAD p-value
Mean ± SE
Age <50 2.74 ± 0.06 0.10
Age 50 3.21 ± 0.07 0.10
Gender H 3.24 ± 0.07 0.008
Gender F 2.58 ± 0.05 0.008
Location Rural 2.85 ± 0.07 .
Location Both 2.89 ± 0.06 0.64
Location Urban 3.20 ± 0.07 0.48
Specialty medicines Endoc 3.09 ± 0.07 .
Specialty medicines Nut 2.44 ± 0.06 0.55
Specialty medicines GPs 2.44 ± 0.06 0.40
Physical activity None 3.59 ± 0.06 .
Physical activity Occasionally 3.14 ± 0.07 0.14
Physical activity Regularly 2.83 ± 0.07 0.13
Asking patient if practice PA No 1.91 ± 0.03 0.19
Asking patient if practice PA Yes 3.10 ± 0.07 0.19
Medical training on type 2 diabetes No 2.60 ± 0.06 0.46
Medical training on type 2 diabetes Yes 3.16 ± 0.07 0.19
Wanting new medical training on physical activity No 3.01 ± 0.07 0.91
Wanting new medical training on physical activity Yes 3.06 ± 0.06 0.91
Medical training on activity in type 2 diabetes No 3.03 ± 0.06 0.78
Medical training on activity in type 2 diabetes Yes 3.04 ± 0.07 0.78
Medical training on nutrition in type 2 diabetes No 2.73 ± 0.06 0.42
Medical training on nutrition in type 2 diabetes Yes 3.18 ± 0.07 0.42
Medical training on medication in type 2 diabetes No 2.65 ± 0.06 0.41
Medical training on medication in type 2 diabetes Yes 3.20 ± 0.07 0.41
Time for PA prescription <10 Min 3.10 ± 0.06 0.43
Time for PA prescription >10 Min 2.70 ± 0.08 0.43
Importance for dietary rules ES -0.06 [-0.18, 0.04] 0.22
Importance for Monotherapy ES 0.10 [-0.04, 0.25] 0.18
Importance for Bitherapy ES 0.03 [-0.14, 0.20] 0.72
GPs’ BAPAD ES 0.03 [0.01–0.05] 0.03
Each regression coefﬁcient is interpreted as the effect size (ES).
doi:10.1371/journal.pone.0140429.t004
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In multivariate analysis (S2 Fig), factors significantly and independently associated with
patient’s BAPAD were GPs gender (higher BAPAD score for male), HbA1c level (higher
BAPAD score if HbA1c 7% (53 mmol/mol)) and physical activity (lower BAPAD score in
patients managing to practice sport frequently). Compared with the reference frequency which
was “1 to 2 times per week”, the more frequent the sport practice (3 and 4 per week, every day),
the lower the patients BAPAD’s score. Patients asked by their GPs to lose weight exhibited a
propensity for a higher BAPAD score. Finally, the higher the GPs’ BAPAD score, the higher
the patients’ BAPAD score.
Discussion
The originality of this study lies in the planned matching between the GPs and their corre-
sponding patients. It enabled refined analyses of the link between patients’ behavior and their
GPs by accounting for hierarchical data structure through mixed effects linear model with
patients from the same GP considered a cluster. In primary health care settings, cluster sam-
pling is often required when subjects are to be recruited from several practices or practitioners.
[11]. Using this method, we confirmed that the higher the GPs’ BAPAD score, the higher the
type 2 diabetes patient’s BAPAD score.
In our study, the cluster effect, i.e. the link between GPs and their patients as measured
through ICC, was 34%. Developed at the university of Aberdeen, an international database
gathering 210 studies includes such ICCs [12] dealing with both GPs and specialists among
management of various diseases. However, there is little information available concerning GPs
and patients with diabetes, and actually, none of these studies emphasizes ICC for GPs and
type 2 diabetes patients. ICCs (for GP clustering) over 20% were unusual (10% of studies). The
highest ICC referenced was 28%, emphasizing a strong link between GPs and their patients.
The high ICC (34%) we found in our study demonstrated a high cluster effect between type 2
diabetes patients and their GPs, which, to our knowledge, has never been demonstrated.
PA is a central component of type 2 diabetes management. Improvements due to PA in type
2 diabetes include increased insulin sensitivity and responsiveness along with a positive effect
on lipids, blood pressure, cardiovascular events, mortality and quality of life [13]. A planned
epidemiological study in type 2 diabetes patients showed that a 1% increase of HbA1c level is
associated with an increase in the risk of diabetic micro and macroangiopathy [14]. Our results
show higher BAPAD scores in patients with inactive lifestyle and also in patients with unbal-
anced glycemic level. Together with the aforementioned studies’ results [4, 12], it is suggested
that high BAPAD scores might consequently reflect a high risk of serious health problems and
morbidities associated with type 2 diabetes. However, although PA is presented as a corner-
stone for type 2 diabetes patients, it is often difficult to incorporate regular PA into daily lives
[11]. Consistent with previous studies [5], our study showed that most adults with type 2 diabe-
tes do not engage regularly in PA as 54% report no regular PA and less than 27% declared hav-
ing daily PA.
Regarding the main purpose of our study, we found that both practice and representation of
PA were reversely associated with BAPAD score of type 2 diabetes patients. Perceived barriers
are important in the general field of health behavior and more particularly in practicing PA
[15].
Since the main source of information for patients about their diabetes is their GPs, it
appeared essential to incorporate not only the characteristics of patients but also the character-
istics of their GPs into our analysis seeking explanatory variables of patient’s BAPAD score.
According to the Health-Belief Model, perceived barriers decrease the likelihood of engaging in
behavior that might otherwise reduce disease risks, enhance health and help control the signs
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and symptoms once a condition is established [16]. Paradoxically, most people cite their GPs
as their primary source of information regarding healthy lifestyle decisions and yet few studies
have evaluated the influence of the counselling practice of GPs on the perceived barriers of
type 2 diabetes patients towards the practice of PA. Moreover, the possible transmission of bar-
riers to PA from GPs to their type 2 diabetes patients had not been yet assessed.
Thus, identification and improvement of GPs’ barriers to promote PA seem important steps
to enhance the PA of type 2 diabetes patients. Actually, it has been shown that endorsement of
an active lifestyle is more credible coming from a professional who is physically active [17].
However, in our study, we have not found such a link between patient’s BAPAD score and
level of physical activity of GPs. The investigation of general practitioners’ characteristics
showed higher BAPAD score in patients whose GP was a man. A possible explanation might
be that male GPs are less empathic and take less time for patient education, especially to
encourage type 2 diabetes patients to practice PA [18]. Several studies have examined gender
differences in preventive services counselling for patients visiting primary care clinics and have
found contradictory results. Tabenkin et al [19] showed that, compared with male physicians,
female provide more counseling for a variety of cardiovascular risk factors, including diabetes,
whereas Kim et al reported that patients of female physicians received similar quality of care
compared with patients of male physicians [20].
The main limitation of this study is the possibility of selection bias due to a low overall
response rate from GPs (<10%). Such a response rate is quite common according to the litera-
ture [21,22]. Our responders probably are GPs more concerned with type 2 diabetes education,
and particularly with PA. On the contrary, our sample of GPs may also held incorrect beliefs
and not fully understand the benefits of engaging in healthy behaviors, such as PA. Therefore,
it seems difficult to know how the low response rate is affecting our results, but one can easily
hypothesize that GPs’ barriers towards prescription of PA might have been even higher with
physicians who did not answer the survey.
The strength of this study is that it is the first one to assess GPs’ attitudes, knowledge and
practical approaches regarding PA in type 2 diabetes and to seek for possible influence on their
type 2 diabetes patients.
In our view, it is important to measure GPs’ barriers in promoting PA since they may ham-
per the message of delivering health-related benefits. Indeed, while examining the nature of
perceived barriers to PA in both type 2 diabetes patients and their GPs, we found common bar-
riers emerging with a high score, which is consistent with the hypothesis that the beliefs of GPs
might influence the beliefs of their patients. Furthermore, these common barriers are inconsis-
tent with evidence-based medicine, since it has been repeatedly shown that appropriate PA is
safe, effective and important for people with disabilities [23]. Thus, identifying and acting on
GPs’ barriers might act as a lever to increase type 2 diabetes PA.
The research literature proposes a number of strategies that may help with overcoming the
challenge and barriers faced by many type 2 diabetes patients. One particular approach
highlighted by our study is the need for GPs to be informed about the effects of PA. It is imper-
ative that physicians who work with type 2 diabetes patients acknowledge not only their
patients’ barriers, but also their own, in an attempt to respond to their patients’ specific needs
and to deliver a message that encourages participation. Male general practitioners should be
particularly targeted regarding patient education.
In conclusion, we have shown an association between GPs’ barriers in promoting PA and
type 2 diabetes patients’ barriers in practicing regular PA. The strong cluster effect was not just
due to the classical patient based effect. The BAPAD result on diabetic type 2 patients is very
dependent from the GPs’ good practice beyond all the characteristics of GPs. These findings
suggest that modifiable variables influence type 2 diabetes patients’ response to PA. To meet
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these challenges, interventions that intend to increase PA should be multifactorial and multidi-
rectional, i.e. directed towards patients and their physicians. This management should be per-
sonalized and adapted for patients and their GPs. GPs and patients would benefit from a
network of professionals specialized in PA for patients with diabetes. Thus, GPs could prescribe
and patients could practice PA safely.
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